Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell LymphomaSolomon A. Graf, Ajay K. Gopal, Fatemeh Behnia et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 13
289 | MULTICENTER REAL‐WORLD OUTCOMES OF FRONTLINE POLA‐R‐CHP IN TREATMENT NAÏVE DLBCLAlex F. Herrera, Liangyi Chen, Sophie Buller et al.|Hematological Oncology|2025Cited by 2
Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphomaVarun Iyengar, Pallawi Torka, Jomel Meeko Manzano et al.|Blood|2025Cited by 1